Daniel Bach

Daniel Bach is a plaintiff-side class actions litigator. He represents individuals, governments, asset managers and pension funds in complex securities, product liability, medical device and consumer protection class actions. He has argued before the Supreme Court of Canada, the Ontario Court of Appeal and the British Columbia Court of Appeal.  Daniel is admitted in Ontario, British Columbia and New York.

Daniel has acted in some of Canada’s most significant securities class actions. He was counsel in Arctic Glacier and IMAX, the first two cases granted leave under Part XXIII.1 of the Securities Act, both of which also certified common-law misrepresentation claims. He represented the class in Manulife and Sino-Forest, two of the largest securities class actions in Canadian history. Daniel also helped recover more than $100 million for class members in the foreign exchange conspiracy class action.

Daniel’s product liability work focuses on complex mass tort claims. He acts for the class in the certified class action against Juul concerning the marketing and safety of its products. He is lead counsel in class actions against Syngenta relating to its paraquat-containing products, including Gramoxone, which were certified in Québec and nationally. Daniel successfully argued certification for women implanted with transvaginal mesh products and recovered tens of millions of dollars for class members.

Daniel leads the firm’s consumer protection practice. His consumer protection work addresses systemic business practices affecting large groups of consumers, including utility charges, courier brokerage fees and product marketing.

Daniel received his B.A. (Hon.) in Political Science and History from the University of Toronto and his J.D. from the University of Toronto Faculty of Law. His academic writing appears in the Canadian Business Law Journal and the Canadian Class Action Review. 

Before joining Siskinds, he practised securities and complex commercial litigation in New York.